Market Tracker

09/30 5:16pm ET

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

46.01
Delayed Data
As of Sep 30
 -0.28 / -0.60%
Today’s Change
45.76
Today|||52-Week Range
66.55
-29.91%
Year-to-Date
Amgen (AMGN) Migraine Drug Hits Phase III Primary Endpoint
Sep 30 / Zacks.com - Paid Partner Content
The Internet of Medical Things: 6 Stocks in Focus
Sep 26 / Zacks.com - Paid Partner Content
These Dogs May Soon Have Their Day
Sep 30 / TheStreet.com - Paid Partner Content
3 Dirt-Cheap Dividend Stocks You Can Buy Right Now
Sep 24 / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Teva Pharmaceutical Industries, Intel, Sanofi, Alp...
Sep 27 / Zacks.com - Paid Partner Content
Teva Reports Positive Phase III Tardive Dyskinesia Data
Sep 23 / Zacks.com - Paid Partner Content
Clinton, Trump Share Big-Pharma Attack Goals, Andrew Left Says
Sep 26 / TheStreet.com - Paid Partner Content
Regeneron, Teva Collaborate to Develop Chronic Pain Drug
Sep 21 / Zacks.com - Paid Partner Content
Andrew Left Says Trump and Clinton Agree on Just One Thing
Sep 26 / TheStreet.com - Paid Partner Content
Teva Presents Top-Line Data from Huntington Disease Study
Sep 20 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close46.29
Today’s open46.36
Day’s range45.76 - 46.76
Volume13,276,308
Average volume (3 months)5,818,001
Market cap$47.0B
Dividend yield2.96%
Data as of 4:05pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)-48.62%
Earnings growth (this year)-2.72%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)-3.22%
P/E ratio30.9
Price/Sales2.89
Price/Book1.59

Competitors

 Today’s
change
Today’s
% change
BGNEBeiGene Ltd+1.09+3.67%
OASMOasmia Pharmaceutica...-0.21-6.56%
Data as of 3:59pm ET, 09/30/2016

Financials

Next reporting dateNovember 9, 2016
EPS forecast (this quarter)$1.36
Annual revenue (last year)$19.6B
Annual profit (last year)$1.6B
Net profit margin8.09%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Erez Vigodman
President &
CEO-Global Operations
Carlo de Notaristefani
Corporate headquarters
Petach Tikva, Tel Aviv

Forecasts